Can tuberculosis occur beyond the lungs?

Yes, tuberculosis can affect other parts of the body. Disease outside the lungs is called extrapulmonary tuberculosis, and it can coexist with pulmonary disease.

Extrapulmonary tuberculosis: the records of disease in several organs

Extrapulmonary tuberculosis appears in hospital records as disease of lymph nodes, the tissues surrounding the lungs, the meninges and other sites. It can also occur alongside pulmonary tuberculosis. A large Chinese hospital investigation published in 2020 recorded that coexistence directly, separating people with lung involvement from those with disease confined to other sites. The distinction is anatomical, but the categories used for counting cases introduce another layer. World Health Organization documents recognize disease outside the lungs while assigning patients with both forms to a pulmonary category in a particular reporting framework. A statistical label can therefore contain more than one affected organ.

Wanli Kang and colleagues assembled records for 202,998 inpatients aged at least 15 from 21 hospitals in 15 Chinese provinces. Their retrospective study covered January 2011 through December 2017. Among these inpatients with extrapulmonary tuberculosis, 62.56% also had pulmonary disease. Another 32.64% had an exclusively extrapulmonary form, and 4.80% had multiple extrapulmonary types without pulmonary involvement. These percentages described people already admitted with extrapulmonary disease; they were not estimates for the entire Chinese population or all people infected with tuberculosis bacteria.

The anatomical details made coexistence concrete. Pulmonary disease accompanied 65.31% of the patients with tuberculous pleurisy and 62.64% of those with tuberculous meningitis. The investigators recorded more disease sites than patients, reflecting involvement at multiple locations. Their design collected existing clinical histories and analyzed age and sex associations. It did not establish a mandatory sequence in which lung disease had to end before illness elsewhere began. The patients with simultaneous involvement supplied direct clinical evidence against such a sequence.

The WHO training modules published with a 2019 copyright specify how an anatomical distinction becomes a reporting decision. Their pulmonary category covers lung tissue and includes miliary disease when lesions involve the lungs. A person with both pulmonary and extrapulmonary involvement is classified as a pulmonary case under that framework. The extrapulmonary description includes pleura, lymph nodes, abdominal and genitourinary sites, skin, bones, joints and meninges. It also separates bacteriologically confirmed disease from a clinical diagnosis without bacterial confirmation. Thus, a count of cases labeled extrapulmonary alone need not equal a count of every patient with disease outside the lungs. The Chinese investigators instead retained categories that explicitly captured concurrent involvement.

A smaller 2020 investigation in Chennai examined an inflammatory response associated with extrapulmonary tuberculosis. Gokul Raj Kathamuthu and colleagues compared four groups of 44 participants: people with tuberculous lymphadenitis, pulmonary tuberculosis, latent infection and healthy controls. The lymphadenitis group had cervical lymph-node involvement, and all participants were HIV negative. The researchers measured circulating proteins associated with inflammation, including C-reactive protein and haptoglobin. Several were elevated in the lymphadenitis group compared with healthy controls. The disease site was a lymph node, while the measurements came from blood, documenting a systemic response to a localized anatomical manifestation.

Those measurements had limits as indicators of severity. The protein levels did not show significant associations with lymph-node size, culture grade or single versus multiple involved nodes. After treatment, three measured proteins declined significantly in the lymphadenitis group, while serum amyloid A did not show a significant change. The investigators interpreted the pattern as evidence of systemic inflammation and its modification over time. Their selected groups enabled comparison of disease manifestations; the findings did not establish a standalone blood measurement that reliably mapped the extent of disease. Extrapulmonary tuberculosis had a measurable inflammatory context without every circulating marker tracking every feature of the affected tissue.

The experience of reaching a diagnosis was documented separately in Zanzibar. Melissa Davidsen Jørstad and colleagues enrolled 132 people presenting with suspected extrapulmonary disease at the main referral hospital, reporting their findings in 2018. Sixty-nine were categorized as tuberculosis cases and 63 as non-tuberculosis cases. Among the tuberculosis patients, the median interval from symptoms to a first healthcare visit was 14 days; the median interval from that visit to treatment was 34 days. The median total was 62 days. These were separate medians across patients, rather than components that necessarily add to the reported overall median. The investigators compared interviews with records and treatment cards and found repeated visits at the same healthcare level associated with longer system delays.

The Zanzibar study also recorded reduced working capacity and changes in self-rated health. Patients with lymph-node disease reported a median of 90 days with reduced capacity or stopped work, compared with 30 days among those with other affected sites. These observations concerned a referral-hospital population and people's reported experiences. WHO's March 2026 description places such diverse manifestations within the same disease, identifying kidneys, brain, spine and skin among possible sites alongside the usual lung involvement. The hospital datasets, inflammatory measurements and case definitions document tuberculosis extending across organs, with concurrent pulmonary disease preserved in the clinical record.

Extrapulmonary tuberculosis: the records of disease in several organs

Extrapulmonary tuberculosis: the records of disease in several organs

The Question

The Answer

Read next